Online citations, reference lists, and bibliographies.
← Back to Search

Bioabsorbable Polymer Scaffolds For Tissue Engineering Capable Of Sustained Growth Factor Delivery.

M. Sheridan, L. Shea, M. C. Peters, D. Mooney
Published 2000 · Chemistry, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Engineering new tissues utilizing cell transplantation on biodegradable polymer matrices is an attractive approach to treat patients suffering from the loss or dysfunction of a number of tissues and organs. The matrices must maintain structural integrity during the process of tissue formation, and promote the vascularization of the developing tissue. A number of molecules (angiogenic factors) have been identified that promote the formation of new vascular beds from endothelial cells present within tissues, and the localized, controlled delivery of these factors from a matrix may allow an enhanced vascularization of engineered tissues. We have developed a gas foaming polymer processing approach that allows the fabrication of three-dimensional porous matrices from bioabsorbable materials (e.g., copolymers of lactide and glycolide [PLG]) without the use of organic solvents or high temperatures. The effects of several processing parameters (e.g., gas type, polymer composition and molecular weight) on the process were studied. Several gases (CO(2), N(2), He) were utilized in the fabrication process, but only CO(2) resulted in the formation of highly porous, structurally intact matrices. Crystalline polymers (polylactide and polyglycolide) did not form porous matrices, while amorphous copolymers (50:50, 75:25, and 85:15 ratio of lactide:glycolide) foamed to yield matrices with porosity up to 95%. The mechanical properties of matrices were also regulated by the choice of PLG composition and molecular weight. Angiogenic factors (e.g., vascular endothelial growth factor) were subsequently incorporated into matrices during the fabrication process, and released in a controlled manner. Importantly, the released growth factor retains over 90% of its bioactivity. In summary, a promising system for the incorporation and delivery of angiogenic factors from three-dimensional, biodegradable polymer matrices has been developed, and the fabrication process allows incorporation under mild conditions.
This paper references
10.1007/978-1-4612-4154-6
Synthetic Biodegradable Polymer Scaffolds
A. Atala (1997)
10.1177/10454411950060030501
The pathophysiology of angiogenesis.
P. Polverini (1995)
10.1016/S0022-5347(17)32671-X
Endoscopic treatment of vesicoureteral reflux with a chondrocyte-alginate suspension.
A. Atala (1994)
10.1016/0032-3861(94)90953-9
Preparation and characterization of poly(l-lactic acid) foams
A. Mikos (1994)
10.1002/(SICI)1097-4636(19971205)37:3<413::AID-JBM12>3.0.CO;2-C
Long-term engraftment of hepatocytes transplanted on biodegradable polymer sponges.
D. Mooney (1997)
10.1097/00006534-199111000-00001
Synthetic Polymers Seeded with Chondrocytes Provide a Template for New Cartilage Formation
C. Vacanti (1991)
10.1163/156856298X00389
Release from alginate enhances the biological activity of vascular endothelial growth factor.
M. C. Peters (1998)
10.1073/PNAS.88.21.9377
Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces.
V. Sluzky (1991)
Biocompatibility of clinical implant materials
D. Williams (1981)
10.1007/3-540-10204-3
Properties of Polymers
D. W. V. Krevelen (1990)
10.1089/ten.1995.1.107
Fabricating tubular devices from polymers of lactic and glycolic Acid for tissue engineering.
D. Mooney (1995)
10.1115/1.2804373
The Role of Gas Dissolution and Induced Crystallization During Microcellular Polymer Processing: A Study of Poly (Ethylene Terephthalate) and Carbon Dioxide Systems
D. Baldwin (1995)
10.1163/156856297X00173
Injectable microcapsules prepared with biodegradable poly(alpha-hydroxy) acids for prolonged release of drugs.
Y. Ogawa (1997)
10.1016/0167-7799(90)90139-O
Alginate as immobilization matrix for cells.
O. Smidsrød (1990)
10.1021/JA950416Q
Specific Intermolecular Interaction of Carbon Dioxide with Polymers
S. G. Kazarian (1996)
10.1016/0963-6897(95)00025-S
Implantable biohybrid artificial organs.
C. Colton (1995)
10.1002/(SICI)1097-0290(19960520)50:4<422::AID-BIT9>3.0.CO;2-N
Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes
D. Mooney (1996)
10.1016/0142-9612(91)90107-L
Controlled and modulated release of basic fibroblast growth factor.
E. Edelman (1991)
10.1089/TEN.1997.3.149
Increased Vascularization and Heterogeneity of Vascular Structures Occurring in Polyglycolide Matrices Containing Aortic Endothelial Cells Implanted in the Rat
W. Holder (1997)
10.1007/0-306-46803-4_1
Protein delivery from biodegradable microspheres.
J. Cleland (1997)
10.1016/S0002-9440(10)65284-4
Vascular endothelial growth factor (VEGF)-mediated angiogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression.
J. Nör (1999)
10.1016/0142-9612(96)87284-X
Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents.
D. Mooney (1996)
10.1002/(SICI)1097-4636(199707)36:1<1::AID-JBM1>3.0.CO;2-P
Ectopic bone formation by marrow stromal osteoblast transplantation using poly(DL-lactic-co-glycolic acid) foams implanted into the rat mesentery.
S. L. Ishaug-Riley (1997)
10.1021/BC00034A002
Biodegradable polymers for protein and peptide drug delivery.
W. Gombotz (1995)
10.1007/978-1-4612-4154-6_4
Synthesis and Properties of Biodegradable Polymers Used as Synthetic Matrices for Tissue Engineering
W. Wong (1997)
10.1557/PROC-252-273
Controlled Release of Fibroblast Growth Factor: Activity in Cell Culture
M. Nugent (1991)
10.1097/00006534-199408000-00001
Cartilage Engineered in Predetermined Shapes Employing Cell Transplantation on Synthetic Biodegradable Polymers
W. Kim (1994)
10.1002/BIT.260420606
Prevascularization of porous biodegradable polymers
A. Mikos (1993)
10.1002/(SICI)1097-4636(199808)41:2<322::AID-JBM18>3.0.CO;2-M
Engineering smooth muscle tissue with a predefined structure.
B. Kim (1998)
10.1038/367258A0
Double-walled polymer microspheres for controlled drug release
K. Pekarek (1994)
10.1002/JCP.1041520225
Calcium alginate beads as a slow‐release system for delivering angiogenic molecules In Vivo and In Vitro
E. C. Downs (1992)
10.1002/(SICI)1097-4636(19981205)42:3<396::AID-JBM7>3.0.CO;2-E
Open pore biodegradable matrices formed with gas foaming.
L. Harris (1998)
Tissue engineering : Frontiers in biotechnology
R. Langer (1993)
10.1089/ten.1995.1.15
Fabrication of controlled release biodegradable foams by phase separation.
H. Lo (1995)
10.1002/JBM.820290807
Biodegradable sponges for hepatocyte transplantation.
D. Mooney (1995)



This paper is referenced by
10.1002/ADMA.200501210
Ultraporous Nanosheath Materials by Layer‐by‐Layer Deposition onto Co‐continuous Polymer‐Blend Templates
X. Roy (2006)
10.3109/10611860108998777
Controlled Release from Coated Polymer Microparticles Embedded in Tissue-engineered Scaffolds
Y. Hu (2001)
10.1002/mabi.201000222
Release kinetics and in vitro bioactivity of basic fibroblast growth factor: effect of the thickness of fibrous matrices.
Min Sup Kim (2011)
SYNTHESIS AND CHARACTERIZATION OF BIOCOMPATIBLE MULTICOMPONENT POLYMER SYSTEMS AS SUPPORTS FOR CELL CULTURES
Aleksandra Porjazoska (2004)
10.1007/s10853-011-6063-x
Bioactive ceramics: processing, structures and properties
J. A. Juhasz (2011)
10.1016/j.biomaterials.2011.02.032
The pro-angiogenic properties of multi-functional bioactive glass composite scaffolds.
Lutz-Christian Gerhardt (2011)
10.1016/B978-0-08-100961-1.00013-X
Growth factors for oral and maxillofacial regeneration applications
M. Tahriri (2017)
10.1007/978-981-13-3705-5_11
Biopolymeric Scaffolds for Tissue Engineering Application
N. Ranganathan (2019)
10.1007/S10853-007-1533-X
Preparation and characterisation of controlled porosity alginate hydrogels made via a simultaneous micelle templating and internal gelation process
S. Partap (2007)
10.1111/j.1749-6632.2009.05082.x
Vascularization shaping the heart
Ayelet Lesman (2010)
10.1016/J.COSSMS.2003.12.004
Supercritical fluid technologies and tissue engineering scaffolds
R. Quirk (2004)
10.1016/S1054-8807(03)00089-9
Biopolymeric delivery matrices for angiogenic growth factors.
A. Zisch (2003)
Applications of Microstereolithography in Tissue Engineering
Andrew Gill (2012)
10.1039/B008188O
Supercritical fluid mixing: preparation of thermally sensitive polymer composites containing bioactive materials
S. Howdle (2001)
19 Angiogenesis and Vascularity for Tissue Engineering Applications
R. Largo (2017)
Modifizierung von Kollagenmatrizes zur Verbesserung der Angiogenese : Eigenschaften von heparinisierten und mit VEGF beladenen Kollagenschwämmen
G. Grieb (2006)
10.1016/S0142-9612(03)00024-3
Dexamethasone-releasing biodegradable polymer scaffolds fabricated by a gas-foaming/salt-leaching method.
J. J. Yoon (2003)
10.1016/B978-012369410-2.50062-0
60 – Cardiac Tissue
M. Radisic (2008)
10.1002/term.540
Overcoming hypoxia to improve tissue‐engineering approaches to regenerative medicine
Erik Bland (2013)
10.1089/107632702753725021
Human recombinant EGF protein delivered by a biodegradable cell transplantation system.
M. Voigt (2002)
10.1023/A:1016592127407
Surface-modified 3D scaffolds for tissue engineering
R. Lenza (2002)
10.1002/BIT.21495
Human endothelial cell growth and phenotypic expression on three dimensional poly(lactide‐co‐glycolide) sintered microsphere scaffolds for bone tissue engineering
E. Jabbarzadeh (2007)
10.1016/J.JCONREL.2005.11.016
Dual release of proteins from porous polymeric scaffolds.
J. Sohier (2006)
10.1016/B978-0-12-398523-1.00030-6
Heart Regeneration: The Bioengineering Approach
D. Seliktar (2014)
10.1002/mabi.201100315
Polymer-based scaffold designs for in situ vascular tissue engineering: controlling recruitment and differentiation behavior of endothelial colony forming cells.
Emanuela S Fioretta (2012)
10.1080/00914037.2011.610070
Development of a Novel Polygalacturonic Acid-Gelatin Blend Scaffold Fabrication and Biocompatibility Studies for Tissue-Engineering Applications
Swati Srivastava (2012)
10.1002/JBM.1251
Drug-releasing scaffolds fabricated from drug-loaded microspheres.
M. Nof (2002)
10.1007/s10856-009-3727-z
Poly (lactic-co-glycolic acid) as a controlled release delivery device
Tee Yong Lim (2009)
10.1163/156856208783432453
Poly(lactic acid) scaffold fabricated by gelatin particle leaching has good biocompatibility for chondrogenesis
Y. Gong (2008)
10.1016/J.JCOU.2017.12.012
Preparation and stability of dexamethasone-loaded polymeric scaffolds for bone regeneration processed by compressed CO2 foaming
Leticia Goimil (2018)
10.1007/s40843-017-9023-9
Degradable, absorbable or resorbable—what is the best grammatical modifier for an implant that is eventually absorbed by the body?
Y. Liu (2017)
10.1016/J.JCONREL.2005.02.022
Neurotrophin releasing single and multiple lumen nerve conduits.
Y. Yang (2005)
See more
Semantic Scholar Logo Some data provided by SemanticScholar